Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2006-08-15
2006-08-15
Monshipouri, Maryam (Department: 1653)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C514S012200
Reexamination Certificate
active
07091316
ABSTRACT:
The present invention relates to a novel protein (MAY-I) which exhibits immunosuppressive activity in allogeneic mixed lymphocyte reaction, and provides a gene encoding that protein, a vector containing said gene, a transformant produced by said vector, a method of manufacturing the said protein with immune activity by culturing said transformant, and a medicinal composition and the like containing the said protein.
REFERENCES:
patent: 5972369 (1999-10-01), Roorda et al.
patent: WO 95/10526 (1995-04-01), None
Nishimura et al., cDNA and deduced amino acid sequence of human PK-120, a plasma kallikrein-sensitive glycoprotein, FEBS Letters, (1995), 357, p. 207-211.
Eiji Kobayashi, et al., “(3) Endogenous immunosuppressive substances induced by blood transfusion,” Japanese Journal of Transfusion Medicine, vol. 45, No. 6, 45 (6), 1999 pp. 783.
Hiroo Uchida, et al., “Characterization of humoral immunosuppressive factors induced after allogeneic blood transfusion and their application for organ transplantation,” Japanese Journal of Clinical Immunology, vol. 23 (6), Dec. 2000, pp. 627-629.
G. Opelz, “Comparison of Random Transfusions With Donor-Specific Transfusions for Pretreatment of HLA One-Haplotype-Matched Related Donor Kidney Transplant Recipients, Transplantation Proceedings,” vol. XVII, No. 6 (Dec.), 1985, pp. 2357-2361.
Anatolij Horuzsko, et al., “Non-cytotoxic blocking antibodies and suppressor cells induced by donor-specific transfusions in healthy volunteers and potential kidney transplant recipients,” Immunology Letters, 26 (1990) pp. 127-130.
Gerhard Opelz, et al., “Poor Kidney-Transplant Survival in Recipients With Frozen-Blood Transfusions or No Transfusions,” The Lancet, Sep. 21, 1974, pp. 696-698.
Hector Marino, et al., “Experimental Skin Homografts; Effect of Homohemotherapy on Their Survival Time,” American Journal of Surgery, vol. 95, Feb. 1958, pp. 267-273.
R. L. Marquet, et al., “Specific Inhibition of Organ Allograft Rejection by Donor Blood,” Transplantation Proceedings, vol. III, No. 1 (Mar.), 1971, pp. 708-710.
J.W. Fabre, et al., “The Effect of Donor Strain Blood Pretreatment on Renal Allograft Rejection in Rats,” Transplantation, vol. 14, No. 5, Nov. 1972, pp. 608-615.
David Cranston, et al., “Abrogation of the Immunosuppressive Effect of Donor Spleen Cells on Renal Allografts in the Rat by Irradiation or Heat Treatment,” Transplantation, vol. 42, No. 3, Sep. 1986, pp. 302-306.
Margaret J. Dallman, et al., “Peripheral Tolerance to Alloantigen Results from Altered Regulation of the Interleukin 2 Pathway,” J. Exp. Med. vol. 173, Jan. 1991, pp. 79-87.
P. S. Nagarkatti, et al., “Induction of Antibodies by Blood Transfusions Capable of Inhibiting Responses in MLC,” Transplantation, vol. 36, No. 6, Dec. 1983, pp. 695-699.
William E. Downey III, et al., “Association of Donor-Specific Blood Transfusion Enhancement of Rat Renal Allografts With Accelerated Development of Antiidiotypic Antibodies and Reduced Alloantibody Responses,” Transplantation, vol. 49, No. 1, Jan. 1990, pp. 160-166.
William M. Baldwin III, et al., “IgM and IgG Alloantibody Production by Splenocytes and Deposition in Rat Renal Allografts are Decreased by Donor-Specific Blood Transfusion,” Transplantation, vol. 51, No. 2, Feb. 1991, pp. 481-485.
Hitoshi Nishimura, et al., “cDNA and deduced amino acid sequence of human PK-120, a plasma kallikrein-sensitive glycoprotein,” FEBS Letters, 357, 1995, pp. 207-211.
E. Soury, et al., “The H4P Heavy Chain of Inter-α-inhibitor Family Largely Differs in the Structure and Synthesis of Its Prolin-Rich Region from Rat to Human,” Biochemical and Biophysical Research Communications, 243, 1998, pp. 522-530.
Ken Hashimoto, et al., “Primary Structure of the Pig Homologue of Human IHRP: Inter-α-Trypsin Inhibitor Family Heavy Chain-Related Protein,” J. Biochem., 119, 1996, pp. 577-584.
Ken-ichi Saguchi, et al., “Cloning and Characterization of cDNA for Inter-α-Trypsin Inhibitor Family Heavy Chain-Related Protein (IHRP), a Novel Human Plasma Glycoprotein,”J. Biochem., 117, 1995, pp. 14-18.
Choi-Miura N. H., et al., “Purification and Characterization of a Novel Glycoprotein Which Has Significant Homology to Heavy Chains of Inter-α-Trypsin Inhibitor Family from Human Plasma,” J. Biochem., vol. 117, No. 2, 1995, pp. 400-407.
Gonzalez-Ramon, N., et al., “The Major Acute Serum Protein in Pigs in Homologous to Human Plasma Kallikrein Sensitive PK-120,” FEBS Letters, vol. 371, No. 3 (1995) pp. 227-230.
Cai, Tao, et al., “Identification of mouseitih-4 encoding a glycoprotein with two EF-hand motifs from early embryonic liver,” Biochemica et Biophysica Acta, vol. 1398, No. 1 (1998) pp. 32-37.
Pineiro, Matilde, et al., “ITIH4 Serum Concentration Increases during Acute-Phase Processes in Human Patients and Is Up-Regulated by Interleukin-6 in Hepatocarcinoma HepG2 Cells,” Biochemical and Biophysical Research Communications, Academic Press Inc., vol. 263 (1999) pp. 224-229.
Gonzalez-Ramon, N., et al., “Pig MAP/ITIH4 and haptoglobin are interleukin-6-dependent acute-phase plasma proteins in porcine primary cultured hepatocytes,” European Journal of Biochemistry, vol. 267 (2000) pp. 1878-1885.
Choi-Miura, N.-H., et al., “The novel acute phase protein, IHRP, inhibits actin polymerization and phagocytosis of polymorphonuclear cells,” Inflammation Research, vol. 49, No. 6 (2000) pp. 305-310.
Nikolic, Goran, et al., “Acute Phase Profile of Novel Plasma Protein sgp120 (PK-120),” Immunoregulation in Health and Disease, (1997) pp. 235-242.
Uchida, H., et al., “Mechanisms of Immunomodulation Induced by Blood Transfusion: Identification of Humoral Factors,” Transplantation Proceedings, vol. 32, No. 2 (2000) pp. 255-256.
Fujimura Akio
Kitoh Yasuhiko
Kobayashi Eiji
Tanaka Hirokazu
Uchida Hiroo
Knobbe Martens Olson & Bear LLP
Maruho Co. Ltd.
Monshipouri Maryam
Rooke Agnes
LandOfFree
Protein induced by homogeneous blood transfusion and DNA... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein induced by homogeneous blood transfusion and DNA..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein induced by homogeneous blood transfusion and DNA... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3716840